Live tape
Top 8, mentions 7d13,436NVDA3,188 mentions▲ +0.04GOOGL2,398 mentions▲ +0.04AMD1,783 mentions▲ +0.08QQQ1,557 mentions▲ +0.05SPY1,555 mentions▲ +0.06SPCX1,052 mentions▲ +0.05TSLA977 mentions▲ +0.05AAPL926 mentions▲ +0.05

Equity · Healthcare

ALNY

NASDAQ

Alnylam Pharmaceuticals (ALNY)

155.95 USD −0.23% vs prior close Nov 6, 2026
Alnylam Pharmaceuticals, Inc. price graph
63 sessions
300 150 11 Aug 6 Nov

The line runs 221 USD on 11 August through 155.95 USD on 6 November, on a scale from 150 to 300. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView
Market cap
20.9B USD
P/E (TTM)
66.9
Revenue, year to Dec 2025
3.7B USD
EPS, diluted, year to Dec 2025
2.33 USD
52-week range
155.95 USD – 473 USD
Avg volume
159.2K
Mentions, 30 days
3

as of Nov 6, 2026

Have Alnylam Pharmaceuticals (ALNY) insiders bought or sold shares recently?

In the 90 days to 9 Nov 2026, Alnylam Pharmaceuticals insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 2 Mar 2026, show no open-market purchase.

Form 4, 90 days to 9 Nov 2026, newest reported trade 2 Oct 2026

Buys 0Sells 1Net sold $399KOther filings 1

Have Alnylam Pharmaceuticals (ALNY) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
02 Oct 2026SUPRAN BRYANEVP, CLO and SecretarySell1,758399K USD
1 other filing in the window: a grant, exercise, tax withholding or transfer, not a trade
Have Alnylam Pharmaceuticals (ALNY) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
19 Sep 2026Greenstreet YvonneChief Executive OfficerAward107

Which funds hold Alnylam Pharmaceuticals (ALNY)?

0 of the 45 institutional funds we track reported a Alnylam Pharmaceuticals position for the quarter ended 30 Sep 2026; the latest of those filings landed 06 Nov 2026.

Form 13F

Which funds hold Alnylam Pharmaceuticals (ALNY)?
FundPositionSharesValueShares q/q
Fisher Asset ManagementExited

Have members of Congress traded Alnylam Pharmaceuticals (ALNY)?

The most recent congressional trade disclosed in Alnylam Pharmaceuticals is a sale by Jefferson Shreve (house, IN), dated 12 May 2025.

STOCK Act disclosures

Have members of Congress traded Alnylam Pharmaceuticals (ALNY)?
TradedMemberTypeAmountFiled after
12 May 2025Jefferson Shrevehouse · Republican–INSale15K USD–50K USD41 days
29 Jan 2024Josh Gottheimerhouse · Democrat–NJSale1K USD–15K USD17 days
11 Jan 2024Josh Gottheimerhouse · Democrat–NJPurchase1K USD–15K USD35 days
11 Dec 2023Josh Gottheimerhouse · Democrat–NJSale1K USD–15K USD27 days
06 Mar 2023Daniel S. Goldmanhouse · Democrat–NYPurchase15K USD–50K USD42 days
28 Sep 2022Josh Gottheimerhouse · Democrat–NJPurchase1K USD–15K USD18 days
13 Nov 2020Josh Gottheimerhouse · Democrat–NJSale1K USD–15K USD26 days

What has been filed or recorded for Alnylam Pharmaceuticals (ALNY)?

The filings we hold for Alnylam Pharmaceuticals, newest first: 1 fails-to-deliver day, 3 quarterly earnings reports, 4 annual reports and 5 reported financial figures, the latest dated 01 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Alnylam Pharmaceuticals (ALNY)?
And
01 Oct 2026Fails to deliverShares failed to deliver3 shares740 USD notional · <0.001% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS 15.72 USD
30 Sep 2026FinancialsTotal assets8.0B USDat period end
30 Sep 2026FinancialsTotal equity3.6B USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS 1.21 USD
31 Dec 2025Annual reportFY 2025 reportedEPS 2.33 USD
31 Dec 2025FinancialsRevenue3.7B USDfiscal year
31 Dec 2025FinancialsNet income313.7M USDfiscal year
31 Dec 2025FinancialsDiluted EPS2.33 USDfiscal year
30 Sep 2025Annual reportFY 2025 reportedEPS 1.51 USD
30 Jun 2025Annual reportFY 2025 reportedEPS −0.70 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.44 USD
31 Dec 2024Annual reportFY 2024 reportedEPS −2.18 USD

What is Reddit saying about Alnylam Pharmaceuticals (ALNY)?

Reddit mentioned ALNY 3 times in the 30 days to 9 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 67% read bullish, 33% bearish and 0% neither. Reddit data updated 9 November 2026.

30-day window, Method

Mentions, 30 days 3Communities 1

How do Reddit mentions of Alnylam Pharmaceuticals (ALNY) compare with its price?

Share ↗
Post on X Share on Reddit Share on LinkedIn
3 mentions

Where Alnylam Pharmaceuticals (ALNY) is discussed

30 days

Where Alnylam Pharmaceuticals (ALNY) is discussed
CommunityShareMentionsNet sentiment
r/wallstreetbets100%3−0.21

Alnylam Pharmaceuticals (ALNY): frequently asked questions

From live data
155.95

What did Alnylam Pharmaceuticals shares close at?

Alnylam Pharmaceuticals closed at 155.95 USD on 6 Nov 2026, down 0.23% on the close before. That is the end-of-day price from Finazon, not a live quote.

20.9B

What is Alnylam Pharmaceuticals’ market cap?

Alnylam Pharmaceuticals is worth 20.9B USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.

66.9

What is Alnylam Pharmaceuticals’ P/E ratio?

Alnylam Pharmaceuticals has a price-to-earnings ratio of 66.9, as of 6 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.

3.7B

What is Alnylam Pharmaceuticals’ revenue?

Alnylam Pharmaceuticals reported revenue of 3.7B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

1 sale

Have Alnylam Pharmaceuticals insiders bought or sold shares recently?

In the 90 days to 9 Nov 2026, Alnylam Pharmaceuticals insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 2 Mar 2026, show no open-market purchase. A further 1 filing was a grant, award, gift or exercise rather than an open-market trade. See Insiders

0 of 45

Which funds own Alnylam Pharmaceuticals?

0 of the 45 funds we track reported a Alnylam Pharmaceuticals position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds

7 trades

Have members of Congress traded Alnylam Pharmaceuticals?

Yes. 7 trades in Alnylam Pharmaceuticals appear in the congressional disclosures we hold; the latest is a sale by Jefferson Shreve (House, IN) dated 12 May 2025, filed 22 Jun 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

15.72

When did Alnylam Pharmaceuticals last report earnings?

Alnylam Pharmaceuticals last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 15.72 USD; no next date is announced in SEC filings yet. See Filings

0 mentions

What is Reddit saying about Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals was mentioned 0 times in the last 7 days across the finance subreddits we track, and 3 times over the trailing 30 days. Of the 3 mentions scored for sentiment, 67% read bullish and 33% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARForm 4 filings (insider transactions)
  5. SEC EDGAR13F filings
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SECSEC fails-to-deliver (CNS) data
  8. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  9. SEC EDGARreported earnings figures and scheduled report dates
  10. SEC EDGARValuation computed from SEC EDGAR filings